(No ratings)
Dr. Mark S. Gold, MD is an internist in Gainesville, FL specializing in internal medicine (adult medicine) and addiction medicine.
1600 Sw Archer Road
Gainesville, FL 32610
He has a state license in Florida.
Licensed In: Florida
Dr. Mark S. Gold, MD does not have any reviews yet, be the first to leave a review of Dr. Mark S. Gold, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mark S. Gold, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Emergent BioSolutions Inc. |
$232,395
Narcan $33,731 |
$198,663 |
|||
---|---|---|---|---|---|
AXOGEN |
$179,961
NERVE CUFF $93,859 |
AxoGuard Nerve Connector $37,750 |
AxoGuard Nerve Protector $4,683 |
AVANCE NERVE GRAFT $259 |
$43,410 |
VIEWRAY TECHNOLOGIES INC |
$85,990
MRIDIAN $85,944 |
$46 |
|||
ADAPT Pharma Inc. |
$53,591
NALOXONE $53,591 |
||||
Magstim Group Inc. |
$40,019
$40,019 |
||||
Other |
$33,381
MRIDIAN SYSTEM $13,553 |
VIEWRAY SYSTEM $4,975 |
$14,852 |
Consulting Fee | $377,557 |
---|---|
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $132,375 |
Honoraria | $66,850 |
Travel and Lodging | $37,778 |
Food and Beverage | $10,757 |
Other | $19 |
This table describes ownership payments received by Dr. Mark S. Gold, MD.
AXOGEN | 2017 | $6,532,764.00 | Immediate family member | Common Stock Interest |
Xhale, Inc. | 2015 | $2,226,458.00 | Immediate family member | Stock |
Xhale, Inc. | 2014 | $2,201,457.00 | Immediate family member | Stock |
Xhale, Inc. | 2013 | $2,171,180.00 | Immediate family member | Stock |
AXOGEN | 2016 | $2,099,817.00 | Immediate family member | Common Stock Interests |
Xhale, Inc. | 2016 | $2,061,388.00 | Immediate family member | Stock |
AXOGEN | 2017 | $1,821,988.00 | Physician Covered Recipient | Common stock interests |
AXOGEN | 2015 | $1,166,565.00 | Immediate family member | Common Stock Options |
AXOGEN | 2013 | $1,121,754.53 | Immediate family member | COMMON STOCK OPTIONS |
AXOGEN | 2017 | $980,000.00 | Physician Covered Recipient | Common Stock Interest |
AXOGEN | 2014 | $837,593.67 | Immediate family member | Common Stock Options |
AXOGEN | 2016 | $585,639.00 | Physician Covered Recipient | Common Stock Options |
Xhale, Inc. | 2015 | $376,846.00 | Physician Covered Recipient | Stock |
Xhale, Inc. | 2014 | $376,281.00 | Physician Covered Recipient | Stock |
VIEWRAY INC | 2014 | $351,072.30 | Physician Covered Recipient | Series A & B Preferred Stock & Options to purchase common stock |
Xhale, Inc. | 2013 | $320,358.00 | Physician Covered Recipient | Stock |
VIEWRAY INC | 2013 | $308,082.65 | Physician Covered Recipient | STOCK AND STOCK OPTIONS |
AXOGEN | 2015 | $306,605.00 | Physician Covered Recipient | Common Stock Options |
AXOGEN | 2018 | $306,450.00 | Physician Covered Recipient | Common Stock Interest |
VIEWRAY TECHNOLOGIES INC | 2015 | $297,709.50 | Immediate family member | Common stock |
Dr. Mark Gold is an addiction medicine specialist in Gainesville, FL. He studied medicine at the University of Florida College of Medicine. Dr. Gold trained at a hospital affiliated with Yale University for his residency.